Article
Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant.
Molecular carcinogenesis - 1 Jul 2017
Poi Ming J, Li Junan, Sborov Douglas W, VanGundy Zachary, Cho Yu Kyoung, Lamprecht Misty, Pichiorri Flavia, Phelps Mitch A, Hofmeister Craig C
Abstract excerpt
Multiple myeloma (MM) is a hematologic malignancy characterized by clonal proliferation of plasma cells and overproduction of monoclonal immunoglobins. Treatment with melphalan is currently standard of care for younger and fit patients when followed by hematopoietic stem cell transplantation (HSCT), and in transplant ineligible patients when used in combination regimens. It has been previously shown that changes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.